Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know.
Adverse drug event
Checkpoint inhibitors
Gynaecological oncology
Pseudoprogression
Journal
Korean journal of radiology
ISSN: 2005-8330
Titre abrégé: Korean J Radiol
Pays: Korea (South)
ID NLM: 100956096
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
14
08
2020
revised:
26
01
2021
accepted:
05
03
2021
pubmed:
29
5
2021
medline:
16
10
2021
entrez:
28
5
2021
Statut:
ppublish
Résumé
Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.
Identifiants
pubmed: 34047505
pii: 22.e64
doi: 10.3348/kjr.2020.1299
pmc: PMC8316780
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1310-1322Informations de copyright
Copyright © 2021 The Korean Society of Radiology.
Déclaration de conflit d'intérêts
The authors have no potential conflicts of interest to disclose.
Références
Cancer Treat Rev. 2017 Nov;60:152-157
pubmed: 28992528
Eur Respir J. 2017 Aug 10;50(2):
pubmed: 28798088
Cancer Treat Rev. 2016 Apr;45:7-18
pubmed: 26922661
Clin Cancer Res. 2016 Dec 15;22(24):6051-6060
pubmed: 27535979
Radiographics. 2019 Nov-Dec;39(7):1923-1937
pubmed: 31584861
Clin Imaging. 2020 Jul;63:35-49
pubmed: 32120311
Eur J Cancer. 2018 Jun;96:91-104
pubmed: 29698933
J Clin Oncol. 2017 Dec 20;35(36):4035-4041
pubmed: 29095678
Eur J Radiol. 2020 Oct;131:109217
pubmed: 32861174
Target Oncol. 2020 Feb;15(1):25-35
pubmed: 31925647
Cancer Immunol Res. 2018 Jun;6(6):630-635
pubmed: 29622582
Presse Med. 2018 Nov - Dec;47(11-12 Pt 2):e253-e259
pubmed: 30413332
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Ann Oncol. 2019 Jul 1;30(7):1080-1087
pubmed: 31046082
Int J Mol Sci. 2019 Sep 23;20(19):
pubmed: 31547532
Future Oncol. 2021 Mar;17(8):877-892
pubmed: 33251877
Nat Rev Endocrinol. 2017 Apr;13(4):195-207
pubmed: 28106152
Clin Ther. 2015 Jan 1;37(1):20-38
pubmed: 25592089
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Immune Netw. 2020 Feb 17;20(1):e11
pubmed: 32158599
Radiol Oncol. 2020 Feb 19;54(1):1-13
pubmed: 32074075
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Immunotherapy. 2017 Sep;9(12):951-954
pubmed: 28971748
J Cutan Pathol. 2020 Feb;47(2):154-160
pubmed: 31437317
Clin Immunol. 2014 Jul;153(1):145-52
pubmed: 24780173
Clin Obstet Gynecol. 2020 Mar;63(1):48-63
pubmed: 31833846
Eur Radiol Exp. 2020 Jan 3;4(1):2
pubmed: 31900689
Cancer Treat Rev. 2016 Jul;48:61-8
pubmed: 27362548
J Thorac Oncol. 2018 Jul;13(7):978-986
pubmed: 29738824
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Curr Oncol Rep. 2018 Nov 13;20(12):94
pubmed: 30421009
BMJ. 2018 Mar 14;360:k793
pubmed: 29540345
Radiology. 2015 Jan;274(1):45-63
pubmed: 25531479
J Gastroenterol. 2020 Jun;55(6):653-661
pubmed: 32124082
AJR Am J Roentgenol. 2012 Oct;199(4):W464-76
pubmed: 22997396
Radiology. 2019 Jan;290(1):9-22
pubmed: 30457485
J Immunother Cancer. 2019 Feb 6;7(1):31
pubmed: 30728076
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36
pubmed: 30306584
J Clin Oncol. 2020 Sep 10;38(26):2981-2992
pubmed: 32167863
Drugs. 2014 Nov;74(17):1993-2013
pubmed: 25344022
Ann Transl Med. 2018 Jun;6(11):222
pubmed: 30023385
Clin Nucl Med. 2015 Nov;40(11):e528-9
pubmed: 26284765
Annu Rev Immunol. 2005;23:515-48
pubmed: 15771580
JAMA Oncol. 2019 Mar 1;5(3):393-401
pubmed: 30676622
Drug Target Insights. 2016 May 22;10:9-12
pubmed: 27257369
J Magn Reson Imaging. 2018 May 7;:
pubmed: 29734497
J Clin Oncol. 2016 May 1;34(13):1510-7
pubmed: 26951310
Eur J Cancer. 2016 Jun;60:190-209
pubmed: 27085692
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580
pubmed: 31092901
Clin Cancer Res. 2017 Oct 1;23(19):5737-5744
pubmed: 28679767
Clin Cancer Res. 2017 Aug 15;23(16):4671-4679
pubmed: 28592629
Curr Neurol Neurosci Rep. 2018 Aug 4;18(10):63
pubmed: 30078154
Clin Cancer Res. 2009 Dec 1;15(23):7412-20
pubmed: 19934295
J Clin Oncol. 2019 Jun 10;37(17):1470-1478
pubmed: 30943124
Lancet Oncol. 2017 Mar;18(3):e143-e152
pubmed: 28271869
N Engl J Med. 2018 Jan 11;378(2):158-168
pubmed: 29320654
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-7
pubmed: 32213091
Front Pharmacol. 2017 Oct 18;8:730
pubmed: 29093678
Abdom Radiol (NY). 2019 May;44(5):1917-1927
pubmed: 30790009
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3360-5
pubmed: 17360651
PLoS One. 2019 May 14;14(5):e0216954
pubmed: 31086392
World J Gastroenterol. 2014 Oct 28;20(40):14760-77
pubmed: 25356038
J Clin Oncol. 2017 Mar;35(7):709-717
pubmed: 27646942
Radiology. 2011 Aug;260(2):428-36
pubmed: 21613442
Mol Clin Oncol. 2019 Nov;11(5):439-446
pubmed: 31616560
J Immunother. 2018 May;41(4):208-211
pubmed: 29200081
N Engl J Med. 2012 Jun 28;366(26):2517-9
pubmed: 22658126
Tumour Biol. 2015 Jan;36(1):33-9
pubmed: 25409618
Transl Cancer Res. 2017 Feb;6(1):93-103
pubmed: 28955654
J Clin Oncol. 2019 Nov 1;37(31):2825-2834
pubmed: 31487218
Br J Dermatol. 2017 Apr;176(4):1060-1063
pubmed: 27291635